Five seemingly unconnected Black and ethnic minority Londoners discover they have superpowers in the hit Netflix series "Supacell". The link between them? They all suffer from sickle cell anaemia, a ...
DCGI cleared Phase III trials of Zydus’ Desidustat for sickle cell disease. If proven safe and effective, the oral drug could offer an accessible new treatment option for millions of Indians.
Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...
The first person to ever be cured of sickle cell anemia in Louisiana received revolutionary gene therapy. The treatment is now offered at this hospital.
Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these personalized treatments faster, cheaper, and available to far more patients.
Zydus Lifesciences Limited (Zydus), an innovation-led global lifesciences company, has received permission to conduct a Phase ...
Children with sickle cell anemia are vulnerable to serious infections and stroke, but many do not receive the preventative care that could help them stay healthier for longer, a Children's Hospital ...
Within 12 hours of landing in Florida in January, 2021, Sebastien Beauzile, then 17, was admitted to two separate hospitals. He had come to Florida to surprise his sister for her birthday. But instead ...
Having a part of his spleen removed and a rare chronic disease hasn’t stopped 12-year-old E’Shon Guy from living a normal ...
September Is Sickle Cell Awareness Month. While many people are familiar with sickle cell anemia, sickle cell traits have also plagued our community. Sickle cell trait (SCT) is an inherited blood ...
Sickle Cell Disease affects 1 to 1.4 million people in India with 30 million carriers present The disease is prevalent mainly among tribal populations in specific Indian states Limited healthcare ...
This deals another blow to tebapivat’s development prospects following its May 2026 termination in MDS due to efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results